Skip to content

Observation of the Clinical Efficacy of Thermal Moxibustion in the Recovery Period of Dengue Virus Infection

Observation of the Clinical Efficacy of Thermal Moxibustion in the Recovery Period of Dengue Virus Infection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000161
Enrollment
Unknown
Registered
2026-01-24
Start date
2025-03-20
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dengue fever recovery period

Interventions

conventional treatment group:The conventional treatment plan adopted includes general treatment, symptomatic treatment with medication, and psychological intervention, as follows: 1. General treatment
Thermal moxibustion combined with conventional treatment group:Thermal moxibustion is added to the conventional treatment group for treatment

Sponsors

Guangdong Integrated Traditional Chinese and Western Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Gender is not limited, age range is between 18 and 65 years old. (2) Moderate to severe patients who meet the diagnostic criteria of both traditional Chinese medicine and Western medicine during the recovery period of dengue fever, and have been assessed to have a TCM syndrome score of = 16. (3) The temperature fluctuation within 48 hours before enrollment is less than 37.3 ?. (4) No other moxibustion treatments were received within the first 4 weeks of enrollment. (5) Those who can experience thermal moxibustion sensation. (6) Voluntarily participate in the study and sign an informed consent form Note: Only those who meet the above 6 criteria can be included.

Exclusion criteria

Exclusion criteria: (1) Combined with other serious primary diseases, coagulation dysfunction or hematopoietic system diseases, as well as important organ lesions such as heart, liver, brain, and kidney. (2) Individuals who are intolerant, allergic, or have an allergic constitution to the experimental medication or thermosensitive moxibustion, and have used other experimental medications in the 30 days prior to the baseline visit, or plan to use them during the study period. (3) Researchers have determined that patients who are not suitable to participate in this trial, such as pregnant or lactating women, women with pregnancy plans in the past 6 months, long-term alcohol abuse or history of prohibited drug use, and those who are currently participating in or have participated in other clinical trials in the past 3 months, are not suitable. (4) Patients with mental illnesses or cognitive impairments. (5) Patients in the recovery phase caused by other diseases. (6) Contraindications for meridian detection: those who have adverse reactions to the sound, light, electricity, and magnetic stimulation of the meridian detector. (7) Contraindications for meridian detection: those who wear pacemakers, those who have undergone organ transplantation or metal body transplantation, and those who use implantable devices. (8) Contraindications for meridian detection: those with ulcers at the toe tips of their limbs. (9) Patients with incomplete clinical data and those who are unable to complete questionnaire items. (10) Participants who do not agree to participate in the experiment. (11) Other situations where treatment cannot be coordinated. Note: Those who meet any of the above criteria will not be included.

Design outcomes

Primary

MeasureTime frame
Traditional Chinese Medicine Syndrome Rating Scale;SF-36 Health Status Checklist;

Secondary

MeasureTime frame
Fatigue Scale-14;Hamilton Anxiety Scale;

Countries

China

Contacts

Public ContactLuo Haijun

Guangdong Integrated Traditional Chinese and Western Medicine Hospital

1299361916@qq.com15970972877

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026